Texas 2025 - 89th Regular

Texas Senate 2025 Status of Bills in Conference Committee May 19th, 2025

Meeting Video(s)

TX

Texas 2025 - 89th Regular

Senate Session

Texas Senate Floor Meeting

Bills on the Agenda

TX

Texas 2025 - 89th Regular

Texas Senate Bill SB1

Filed
1/22/25  
Out of Senate Committee
3/19/25  
Voted on by Senate
3/25/25  
Out of House Committee
3/31/25  
Bill Becomes Law
 
General Appropriations Bill.
TX

Texas 2025 - 89th Regular

Texas Senate Bill SB17

Filed
2/20/25  
Out of Senate Committee
3/17/25  
Voted on by Senate
3/19/25  
Out of House Committee
5/6/25  
Bill Becomes Law
 
Relating to the purchase or acquisition of an interest in real property by certain aliens or foreign entities; creating a criminal offense; providing a civil penalty.
TX

Texas 2025 - 89th Regular

Texas Senate Bill SB260

Filed
11/12/24  
Out of Senate Committee
3/10/25  
Voted on by Senate
3/12/25  
Out of House Committee
4/16/25  
Bill Becomes Law
 
Relating to the school safety allotment under the Foundation School Program.
TX

Texas 2025 - 89th Regular

Texas Senate Bill SB509

Filed
11/25/24  
Out of Senate Committee
3/17/25  
Voted on by Senate
3/24/25  
Out of House Committee
4/30/25  
Bill Becomes Law
 
Relating to requiring notice to the attorney general in an action under the Election Code seeking a temporary restraining order.
TX

Texas 2025 - 89th Regular

Texas Senate Bill SB1506

Filed
2/20/25  
Out of Senate Committee
4/10/25  
Voted on by Senate
4/16/25  
Out of House Committee
4/28/25  
Bill Becomes Law
 
Relating to the frequency with which the Board of Pardons and Paroles reconsiders inmates for release on parole.
TX

Texas 2025 - 89th Regular

Texas Senate Bill SB1637

Filed
2/25/25  
Out of Senate Committee
4/3/25  
Voted on by Senate
4/9/25  
Out of House Committee
4/28/25  
Bill Becomes Law
 
Relating to the prosecution of the offense of deadly conduct.
TX

Texas 2025 - 89th Regular

Texas Senate Bill SB2308

Filed
3/11/25  
Out of Senate Committee
4/28/25  
Voted on by Senate
4/30/25  
Out of House Committee
5/12/25  
Voted on by House
5/13/25  
Governor Action
6/11/25  
Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.